Affinity for DNA Contributes to NLS Independent Nuclear Localization of MeCP2

Area of Science:

• Molecular Biology
• Neuroscience
• Genetics

Background:

• MeCP2 is a nuclear protein implicated in the neurological disorder Rett syndrome (RTT).
• Previous studies identified a nuclear localization signal (NLS) in MeCP2, suggesting interaction with nuclear import factors.
• The precise mechanism of MeCP2 nuclear import and retention remains incompletely understood.

Purpose of the Study:

• To investigate the role of the identified NLS in the nuclear localization of MeCP2.
• To determine the contribution of MeCP2's functional domains to its nuclear targeting.
• To explore the implications of MeCP2's nuclear localization mechanism in the context of Rett syndrome.

Main Methods:

• Investigated MeCP2 nuclear localization independent of its previously identified NLS.
• Assessed the sufficiency of the methyl-CpG binding domain (MBD) for nuclear localization.
• Utilized a mouse model of Rett syndrome with an inactivating mutation in the MeCP2 NLS.

Main Results:

• Nuclear localization of MeCP2 was found to be independent of its NLS.
• An intact MBD was sufficient to retain MeCP2 in the nucleus, suggesting DNA binding as a key factor.
• Inactivating the NLS in a mouse model did not affect RTT disease progression.

Conclusions:

• MeCP2 nuclear localization is primarily mediated by its MBD and affinity for DNA, not its NLS.
• There is an unexpected functional redundancy in MeCP2's nuclear targeting mechanisms.
• This redundancy may explain the rarity of NLS-inactivating mutations in causing Rett syndrome.